Publications by authors named "Liuting Yu"

Claim this Profile
T
Tubular epithelial cell-derived Flt3L is required for type 1 conventional dendritic cell (cDC1) activation and expansion in promoting the recovery in acute kidney injury.
Na Li, Stefanie Steiger, Yao Guo, Muzheng Li, Zheqi Wen, Chuyu Xie, Yuming Zhao, Liuting Yu, Yun Chen

J Adv Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3L-based drug conjugate effectively targets chemoresistant leukemia stem cells in acute myeloid leukemia.
Dengyang Zhang, Yao Guo, Zhiyong Peng, Yan Xiao, Zhiguang Chang, Liuting Yu, Yuming Zhao, Yun Chen

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression and perspectives in disease modeling for Juvenile myelomonocytic leukemia.
Shengyuan Fu, Yao Guo, Zhiyong Peng, Dengyang Zhang, Zhiguang Chang, Liuting Yu, Yun Chen, Yuming Zhao

Med Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dysregulated arginine metabolism in precursor B-cell acute lymphoblastic leukemia in children: a metabolomic study.
Wenqing Wang, Liuting Yu, Zhen Li, Yan Xiao, Hao Jiang, Yun Chen

BMC Pediatr· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia.
Yan Xiao, Bingbing Hu, Yao Guo, Dengyang Zhang, Yuming Zhao, Yun Chen, Liuting Yu

Curr Treat Options Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sunitinib selectively targets leukemogenic signaling of mutant SHP2 in juvenile myelomonocytic leukemia.
Chunxiao He, Zhiyong Peng, Dengyang Zhang, Yao Guo, Tianqi Liang, Yuming Zhao, Liuting Yu, Yun Chen

Biochem Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miR-221/222 induce instability of p53 By downregulating deubiquitinase YOD1 in acute myeloid leukemia.
Han Zhong Pei, Zhiyong Peng, Xiaomei Zhuang, Xiaobo Wang, Bo Lu, Yuming Zhao, Yunjun Xiao, Liuting Yu, Yun Chen

Cell Death Discov· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemogenic SHP2 mutations lead to erythropoietin independency of HCD-57 cells: a novel model for preclinical research of SHP2-mutant JMML.
Yuming Zhao, Chunxiao He, Dengyang Zhang, Yao Guo, Zhiyong Peng, Liuting Yu, Yun Chen

Exp Hematol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of SCF drug conjugate targeting c-KIT in gastrointestinal stromal tumor.
Dengyang Zhang, Chunxiao He, Yao Guo, Jianfeng Li, Bo Li, Yuming Zhao, Liuting Yu, Yulong He, Yun Chen

BMC Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia.
Xiaomei Zhuang, Han Zhong Pei, Tianwen Li, Junbin Huang, Yao Guo, Yuming Zhao, Liuting Yu, Yun Chen

Front Oncol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bidirectional Interaction Between Cancer Cells and Platelets Provides Potential Strategies for Cancer Therapies.
Liuting Yu, Yao Guo, Zhiguang Chang, Dengyang Zhang, Shiqiang Zhang, Yun Chen

Front Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of a recombinant FLT3 ligand and its emtansine conjugate as a therapeutic candidate against acute myeloid leukemia cells with FLT3 expression.
Dengyang Zhang, Yao Guo, Yuming Zhao, Liuting Yu, Zhiguang Chang, Jian Yu, Yun Chen

Microb Cell Fact· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered platelets with antithrombotic and antimetastatic properties.
Liuting Yu, Zhizhuang Joe Zhao

Stem Cell Investig· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis